Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects
Ranjan P Malhotra,1 Edward Meier,2 Gail Torkildsen,3 Paul J Gomes,4 Mark C Jasek5 1Ophthalmology Associates, St Louis, MO, USA; 2Apex Eye, Mason, OH, USA; 3Andover Eye, Andover, MA, USA; 4Ora, Inc., Andover, MA, USA; 5Eyevance Pharmaceuticals, Fort Worth, TX, USA Purpose: The studies reported here...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2019-02-01
|
| Saila: | Clinical Ophthalmology |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.dovepress.com/safety-of-cetirizine-ophthalmic-solution-024-for-the-treatment-of-alle-peer-reviewed-article-OPTH |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|